EPS for Quidel Corporation (QDEL) Expected At $-0.17

July 18, 2017 - By Marie Mckinney

 EPS for Quidel Corporation (QDEL) Expected At $ 0.17
Investors sentiment decreased to 0.8 in 2016 Q4. Its down 0.31, from 1.11 in 2016Q3. It dived, as 8 investors sold Quidel Corporation shares while 36 reduced holdings. 8 funds opened positions while 27 raised stakes. 29.80 million shares or 0.16% less from 29.85 million shares in 2016Q3 were reported.
Susquehanna Intll Llp holds 24,353 shares or 0% of its portfolio. Ny State Common Retirement Fund reported 890,655 shares stake. Pitcairn holds 17,206 shares. Cannell Peter B & Com reported 473,800 shares. First Mercantile Tru, a Tennessee-based fund reported 5,240 shares. Zacks Inv Mgmt has 0.02% invested in Quidel Corporation (NASDAQ:QDEL). Morgan Stanley reported 0% in Quidel Corporation (NASDAQ:QDEL). Manufacturers Life Insur Co The holds 0% or 19,123 shares in its portfolio. Blackrock Group Ltd holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 19,982 shares. Sei Invs holds 0% or 3,129 shares. Metropolitan Life Ny stated it has 0% in Quidel Corporation (NASDAQ:QDEL). Moreover, Bankshares Of Mellon Corporation has 0% invested in Quidel Corporation (NASDAQ:QDEL) for 200,645 shares. Retail Bank Of Montreal Can reported 0% in Quidel Corporation (NASDAQ:QDEL). Moreover, Investment Mgmt Of Virginia has 2.03% invested in Quidel Corporation (NASDAQ:QDEL) for 396,488 shares. 55,368 were reported by California State Teachers Retirement Sys.

Since February 24, 2017, it had 0 buys, and 4 selling transactions for $5.07 million activity. BRYANT DOUGLAS C had sold 37,080 shares worth $834,204 on Wednesday, March 29. Bujarski Robert Joseph sold $1.05 million worth of stock.

Wall Street await Quidel Corporation (NASDAQ:QDEL) to release earnings on July, 26. Analysts forecast earnings per share of $-0.17, down exactly $0.02 or 13.33 % from 2014’s $-0.15 EPS. After posting $0.42 EPS for the previous quarter, Quidel Corporation’s analysts now forecast -140.48 % negative EPS growth. The stock increased 25.35% or $6.9 during the last trading session, reaching $34.12. About 1.49M shares traded or 866.25% up from the average. Quidel Corporation (NASDAQ:QDEL) has risen 56.78% since July 18, 2016 and is uptrending. It has outperformed by 40.08% the S&P500.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 7 analysts covering Quidel (NASDAQ:QDEL), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Quidel had 13 analyst reports since September 2, 2015 according to SRatingsIntel. As per Tuesday, February 9, the company rating was downgraded by Canaccord Genuity. As per Friday, January 8, the company rating was maintained by Canaccord Genuity. The stock of Quidel Corporation (NASDAQ:QDEL) earned “Overweight” rating by Barclays Capital on Wednesday, September 2. The rating was downgraded by Piper Jaffray to “Neutral” on Friday, December 16. The company was upgraded on Monday, June 13 by Raymond James. The rating was initiated by CL King on Friday, February 17 with “Neutral”. The company was downgraded on Friday, October 23 by Craig Hallum. The rating was downgraded by Raymond James to “Mkt Perform” on Monday, December 14. The firm has “Neutral” rating given on Friday, December 16 by PiperJaffray.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The company has market cap of $1.14 billion. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. It has a 332.55 P/E ratio. The Firm sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

More important recent Quidel Corporation (NASDAQ:QDEL) news were published by: Businesswire.com which released: “Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July …” on July 14, 2017, also Streetinsider.com published article titled: “Quidel Corp (QDEL) Reports Acquisition of Alere Triage Assets”, Streetinsider.com published: “Quidel Corp (QDEL) Reports FDA Clearance, CLIA Waiver for Point-of-Care Sofia …” on June 28, 2017. More interesting news about Quidel Corporation (NASDAQ:QDEL) was released by: Benzinga.com and their article: “Mid-Afternoon Market Update: Peregrine Pharma Drops After Q4 Results; Quidel …” with publication date: July 17, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.